C4V CHROMO4VIS receives CE Certification under MDR: A historic milestone for Precision Medicine in Ophthalmology
Regensight is proud to announce that C4V CHROMO4VIS, the first theranostic device in ophthalmology, has officially received CE certification under the Medical ...
Regensight is sponsor of the World Keratoconus Congress 2025
We are pleased to announce that Regensight will be Main Sponsor of the World Congress on Keratoconus 2025, which will be held in Athens, Greece, from June 12 to ...
RitSight has been issued the MDR CE Certification
We are thrilled to announce that RitSight, our 0.22% riboflavin ophthalmic solution for corneal cross-linking, has been granted the CE Certificate in conformity ...
The Teracor project for the correction of visual disorders with theranostics is moving forward quickly
We are thrilled to announce an important milestone in our Teracor project! At the Intermediate Progress Report of the project funded with European funds ...
ARGO clinical study published in the prestigious scientific journal Ophthalmology
🔬 Breakthrough Advancement in Clinical Research for the Treatment of Keratoconus 🔬 We are excited to announce the publication of the ARGO clinical trial val ...
Regensight at ESCRS 2024
Regensight will join the most important and awaited International Annual Conference in corneal and cataract surgery organized by ESCRS in Barcelona (https://con ...
New Publication on Regensight: A Clear Future for Young People with Keratoconus
We are excited to announce the publication of a new scientific article, entitled "Spatial targeted delivery of riboflavin with a controlled corneal iontophores ...
RitSight is the riboflavin ophthalmic solution with highest performance for corneal cross-linking
Glad to share the outcomes of a recent manuscript, published on Graefe’s Archive for Clinical & Experimental Ophthalmology, assessing the performance of sev ...
Regensight granted by Lazio Innova for the development of the theranostics platform for the correction of visual disorders
The project n. A0613-2023-077528 of Regensight srl was granted by Lazio Innova in response to the "RSI Competitive Repositioning" Public Notice, FESR Program 20 ...
Great interest in Regensight at the ESCRS 2023
The Regensight team has been an active part of The European Society of Cataract and Refractive Surgery (ESCRS) International Conference, which was held in Vienn ...